Literature DB >> 20642419

Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine.

Mark R Nelson1, Helena C Britt, Christopher M Harrison.   

Abstract

OBJECTIVES: To assess whether the management rate of herpes zoster (HZ) in Australian general practice has changed since varicella vaccines became available; and to ascertain the mean age of patients attending general practice for HZ management, to assist with planning of vaccination to prevent HZ in older Australians. DESIGN, SETTING AND PARTICIPANTS: Retrospective analysis of data for the period April 1998 to March 2009 on 1,078,671 (weighted) management encounters with consecutive patients of 10,885 general practitioners who participated in the BEACH (Bettering the Evaluation and Care of Health) national cross-sectional survey. MAIN OUTCOME MEASURES: Number of encounters for management of HZ (shingles) and of varicella (chickenpox); age of patients presenting for HZ management.
RESULTS: Regression analysis indicated a significant rise in the HZ management rate over the study period, with an average annual increase of 0.05 per 1000 encounters (P < 0.01). The management rate for varicella decreased significantly from 2.01 per 1000 encounters in 1998-1999 to 0.58 per 1000 in 2008-2009. Mean age calculated for each year of the study varied between 10.2 and 15.3 years for patients with varicella, and between 57.5 and 64.1 years for patients with HZ.
CONCLUSIONS: There has been a significant rise in the HZ management rate and a decrease in the varicella management rate in Australian general practice over the period 1998-2009. Introduction of vaccination for HZ prevention at age 60 years should be considered, although addition of this vaccination to the existing schedule for vaccination at age 65 years is also likely to be beneficial and may be more pragmatic.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20642419

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  12 in total

Review 1.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

Review 2.  Varicella vaccination - the global experience.

Authors:  Peter Wutzler; Paolo Bonanni; Margaret Burgess; Anne Gershon; Marco Aurélio Sáfadi; Giacomo Casabona
Journal:  Expert Rev Vaccines       Date:  2017-07-13       Impact factor: 5.217

3.  Factors Predictive of Varicella Zoster Virus Encephalitis/Meningitis: A Single-Center, Retrospective Study.

Authors:  Yanrong Yuan; Jun Wang; Yan Zhang; Huili Liu; Yongxing Yan
Journal:  Med Sci Monit       Date:  2022-09-28

4.  Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain).

Authors:  María D Esteban-Vasallo; M Felicitas Domínguez-Berjón; Ruth Gil-Prieto; Jenaro Astray-Mochales; Angel Gil de Miguel
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

5.  Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.

Authors:  Benson Ogunjimi; Evelien Smits; Steven Heynderickx; Johan Van den Bergh; Joke Bilcke; Hilde Jansens; Ronald Malfait; Jose Ramet; Holden T Maecker; Nathalie Cools; Philippe Beutels; Pierre Van Damme
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

Review 6.  Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review.

Authors:  Benson Ogunjimi; Pierre Van Damme; Philippe Beutels
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

7.  Increasing trends of herpes zoster in Australia.

Authors:  Raina MacIntyre; Alicia Stein; Christopher Harrison; Helena Britt; Abela Mahimbo; Anthony Cunningham
Journal:  PLoS One       Date:  2015-04-30       Impact factor: 3.240

8.  Increasing incidence associated with herpes zoster infection in British Columbia, Canada.

Authors:  Fawziah Marra; Mei Chong; Mehdi Najafzadeh
Journal:  BMC Infect Dis       Date:  2016-10-20       Impact factor: 3.090

9.  Varicella-Zoster Virus in Perth, Western Australia: Seasonality and Reactivation.

Authors:  Igor A Korostil; David G Regan
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

Review 10.  Systematic review of incidence and complications of herpes zoster: towards a global perspective.

Authors:  Kosuke Kawai; Berhanu G Gebremeskel; Camilo J Acosta
Journal:  BMJ Open       Date:  2014-06-10       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.